Bone mineral density in familial partial lipodystrophy

Antía Fernández‐Pombo, Javier A. Ossandon‐Otero, Cristina Guillín‐Amarelle, Sofía Sánchez‐Iglesias, Ana I. Castro, Blanca González‐Méndez, Silvia Rodríguez‐García, Leticia Rodríguez‐Cañete, Felipe F. Casanueva, David Araújo‐Vilar

Clinical Endocrinology · 2017 · 12 citations · 28 references

DOIFull text

Open access

Concepts

Abstract

Summary Objective Type 1 and type 2 familial partial lipodystrophies ( FPLD ) are characterized by the loss or increase in subcutaneous fat in certain body regions, as well as metabolic disorders. Higher muscle volume and mass have also been described. However, so far, possible bone involvement has not been studied. The aim of this study was to evaluate bone mineral density ( BMD ) in patients with type 1 and type 2 FPLD . Methods A total of 143 women were selected and distributed into three groups (17 women with FPLD 2, 82 women with FPLD 1 and 44 nonlipodystrophic obese female controls). A thorough history and physical examination were carried out on all subjects, as well as the measurement of anthropometric features. BMD along with fat and fat‐free mass ( FFM ) were determined by DXA (dual‐energy X‐ray absorptiometry). Statistical analyses, primarily using the χ 2 , ANOVA and ANCOVA tests, were performed, using age, height, fat and FFM as covariables. Results After eliminating the possible influences of age, height, fat and FFM , we observed that there were no significant differences in total BMD between patients with FPLD and the control group, showing total BMD values of 1.092 ± 0.037 g/cm 2 in the FPLD 2 group, 1.158 ± 0.013 g/cm 2 in the FPLD 1 group and 1.173 ± 0.018 g/cm 2 in the control group ( P = .194). Similarly, no significant differences were found in segmental BMD . Conclusions Unlike in other types of laminopathy in which bone is affected, in the case of FPLD , there are no differences in BMD compared to nonlipodystrophic subjects.

References

28